Benign Liver Lesions

Benign Liver Lesions: Intro & Imaging - Lesion Spotting 101

Benign liver lesions are common, non-cancerous growths. Most are asymptomatic, found incidentally during scans for other issues. Accurate diagnosis relies heavily on imaging.

• Incidence: High; many discovered serendipitously.
• Typical Patient: Often asymptomatic; specific demographics vary by lesion type (e.g., FNH in young women).
• Key Diagnostic Features:
  • Imaging is paramount: USG (initial), CT, MRI for detailed characterization.
  • Specific contrast enhancement patterns are crucial for differentiation.
  • Biopsy rarely needed if imaging is classic and no risk factors.
• When to Worry/Intervene:
  • Presence of symptoms (pain, abdominal fullness).
  • Large size (e.g., >5 cm, lesion-dependent).
  • Diagnostic uncertainty or atypical features.
  • Risk/presence of complications (hemorrhage, rupture).

⭐ Most benign liver lesions are asymptomatic and discovered incidentally during imaging for other reasons.

Cavernous Hemangioma - Bloody Good Bumps

• Most common benign liver tumor; often incidental.

• F > M; typically 30-50 years.

• Imaging:

  • US: Hyperechoic.
  • CT/MRI (Contrast): Peripheral, discontinuous, nodular enhancement with centripetal fill-in. Delayed persistent enhancement.

• Management:

  • Asymptomatic: Observe. Biopsy contraindicated (bleeding risk).
  • Symptomatic/Complications (e.g., Kasabach-Merritt syndrome - rare): Resection, enucleation, embolization.

⭐ Characteristic 'peripheral discontinuous nodular enhancement with centripetal fill-in' on CT/MRI is virtually diagnostic.

Focal Nodular Hyperplasia (FNH) - Scar Star Power

• Second most common benign liver lesion.
• Arises from a hyperplastic response to anomalous arteries.
• Key imaging feature: Central scar.
  • CT: Hypo/isoattenuating scar.
  • MRI: Scar typically T1 hypointense, T2 hyperintense.
• Enhancement pattern (CECT/MRI):
  • Arterial phase: Intense, homogeneous hyperenhancement (lesion, not scar).
  • Portal venous/Delayed phases: Iso/hyperdense to liver; scar may show delayed enhancement.
• Generally no malignant potential; observation is typical.
• 📌 "Scar Star": Central scar is the star of the show!

⭐ Focal Nodular Hyperplasia (FNH) often shows avid arterial enhancement and the presence of a T2-hyperintense central scar on MRI.

Hepatocellular Adenoma (HCA) - Risky Business Lesions

• Key associations: Oral Contraceptive Pills (OCPs), anabolic steroids, glycogen storage diseases.
• Significant risks: Spontaneous hemorrhage (can be life-threatening), malignant transformation to HCC.

HCA Subtypes & Key Implications:

Management Strategy:

Hepatic Cysts & Others - Bubble Trouble & Co.

• Simple Cysts:
  • Common, congenital.
  • Imaging: Anechoic (US), water attenuation (CT), T2 bright (MRI).
  • Usually asymptomatic; manage if symptomatic (large, compressing).

  ⭐ Simple hepatic cysts are typically anechoic on ultrasound with posterior acoustic enhancement and well-defined thin walls.

• Biliary Hamartomas (von Meyenburg Complexes):
  • Small, multiple, often incidental.
  • Can mimic metastases but are stable. oka

High‑Yield Points - ⚡ Biggest Takeaways

• Hemangiomas: Most common benign liver tumor; typically asymptomatic, observe. Biopsy contraindicated due to bleeding.
• FNH: Second most common; characteristic central stellate scar on imaging. No malignant potential.
• Hepatic Adenoma: Strong association with OCPs; risk of rupture & malignancy if >5 cm.
• Amoebic Liver Abscess: E. histolytica; anchovy sauce pus, right lobe common; treat with metronidazole.
• Hydatid Cyst: Echinococcus; daughter cysts, calcification; anaphylaxis risk on rupture; albendazole + intervention.
• Pyogenic Liver Abscess: Often polymicrobial; fever, RUQ pain; requires antibiotics and drainage.